A detailed history of Susquehanna Fundamental Investments, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 19,541 shares of URGN stock, worth $184,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,541
Holding current value
$184,857
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$10.52 - $13.11 $205,571 - $256,182
19,541 New
19,541 $208,000
Q3 2021

Nov 15, 2021

SELL
$14.31 - $18.39 $312,401 - $401,472
-21,831 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$15.2 - $20.94 $331,831 - $457,141
21,831 New
21,831 $333,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $215M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.